Chipotle Mexican Grill, Inc. vs Novartis AG — how do they compare? Chipotle Mexican Grill, Inc. trades at $32.3 (market cap $40.49B), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 7.3× Chipotle Mexican Grill, Inc.'s market cap, and Novartis AG pays a 3.07% dividend while Chipotle Mexican Grill, Inc. pays none. Which is the better fit depends on your goals.
| CMG | NVS | |
|---|---|---|
Market Cap | $40.49B | $295.37B |
Sector | Consumer Cyclical | Health |
52-Week High | $44.04 | $168.62 |
52-Week Low | $28.17 | $119.31 |
Enterprise Value | $45.24B | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Read more on CMG →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →